Gamaleya Research Institute of Epidemiology
COVID-19 Vaccines: Moderna declares successful trial results after Pfizer
The new vaccine candidate by Moderna Inc, called mRNA-1273, has reportedly shown 94.5% efficacy against the SARS-CoV-2 in the phase III clinical trials
Even with vaccines, it is a long and rocky road to immunity
Even if the major economies can solve their own problems of procuring the vaccines by jumping the queue with money or captive production capacities, what about the rest of the world?
- Uruguay’s Broad Front government renews search for those disappeared by military dictatorship
- Jordan bans Muslim Brotherhood, confiscates its assets after alleged security plot
- Medics on hunger strike against Gaza genocide reach European Parliament
- Samidoun Europe coordinator targeted again by Belgian police
- Syria’s interim government arrests senior Palestinian resistance leaders
